Thanks to this great era, we are fortunate to be in the high light of the development of nuclear medicine, ‘knowing the shortcomings and making progress, looking at the distant mountains and moving forward’.
MOREFrom June 21 to 23, 2024, the opening ceremony of the Clinical Technical Cooperation support Unit for Medical Physicists (Nuclear medicine) of China National Health Association and the fourth offline practical training course for Medical Physicists (Nuclear medicine) was successfully held in the Third Hospital of Hebei Medical University.
MOREThe State Council Information Office held a regular policy briefing of The State Council at 3 PM on June 14, 2024 (Friday). Li Bin, Deputy Director of the NHC, and officials of the National Medical Insurance Administration, the National Disease Control and Prevention Administration and the National Food and Drug Administration were invited to introduce the Key Tasks of Deepening the Reform of the Medical and Health System in 2024 and answer questions from journalists.
MOREIn order to protect the health of radiation workers, patients and the public, and promote the high-quality development of radiation diagnosis and treatment work, we hereby notify the following matters concerning further radiation monitoring of medical radiation sites in medical institutions.
MOREOn April 22, 2024, CNPC China Tongfu's unit, CNPC Qualcomm, announced that China's first annual output of 10,000 Curie carrier-free Lutetium-177 production line and annual output of 1,000 germanium gallium [68Ge-68Ga] generator production line were fully completed and put into operation
MORE"Carbon-14 irradiation production targets start piling up!" At 13:48 on April 20, with the order, the carbon-14 target was successfully extracted from the Qinshan Nuclear Power heavy water reactor unit invested and controlled by China Nuclear Power (stock code: 601985), a subsidiary of CNNC Group
MOREOn April 11, according to the announcement of the State Food and Drug Administration, human thyroid-stimulating hormone injection (generic celebrity thyroid-stimulating hormone injection, trade name Zhishujia?) was approved for marketing, and the indication is for the adjuvant treatment of iodine [131I] to remove residual thyroid tissue in patients with differentiated thyroid cancer without distant metastasis after total thyroidectomy or near-total thyroidectomy.
MOREThe number of patients with coronary heart disease in China is 11.39 million, and its incidence rate and mortality rate are increasing year by year. The annual medical expenditure is more than 100 billion yuan.
MORENuclear medicine is an important part of modern medicine, and it plays an irreplaceable role in the early and accurate diagnosis, treatment, efficacy monitoring and individualized treatment of diseases, especially major diseases such as tumors, cardiovascular and central nervous system diseases.
MOREProstate cancer, as the second most common cancer in men, has always been a key research area in the medical community for its diagnosis and treatment.
MOREOn December 3, 2023, the kick-off meeting of the "National Pilot Project for High-quality Development and Talent Training of Nuclear Medicine", jointly sponsored by the Talent Exchange Service Center of the National Health Commission and the China Primary Health Care Foundation, and supported by the Nuclear Medicine Branch of the Chinese Medical Association, was successfully held in Beijing.
MOREFrom December 1 to 3, 2023, sponsored by the Nuclear Medicine Branch of the Chinese National Health Association and the Training Department of the Chinese National Health Association, repair and Jiaxing First Hospital undertook, and the Chinese Medical Association Nuclear Medicine Branch as a technical support unit of the third period of medical physicists (nuclear medicine) offline practical training course was successfully held in Jiaxing, Zhejiang
MOREOn November 17, 2023, the 3rd East Asian Nuclear Medicine Joint Academic Conference, the 18th China-Japan Nuclear Medicine Exchange Association Working Conference and the 63rd Annual Conference of the Japan Nuclear Medicine Association and the 43rd Annual Conference of the Japan Nuclear Medicine Technology Society were grandly opened in Osaka, Japan.
MORE[Editor's note] The development of nuclear medicine has been troubled by too much, among which the relevant standards of radiation protection in nuclear medicine have attracted much attention and heated discussion. On September 11, 2023, we received a reply from the Ministry of Ecology and Environment to the Chinese Society for Radiation Protection's "Request for Consultation on relevant Provisions of Nuclear Medicine Standards"
MOREOn June 24, 2021, the China Atomic Energy Authority, the Ministry of Science and Technology and other eight departments officially issued the Medium and Long Term Development Plan for Medical Isotopes (2021-2035)
MOREThe 2023 Annual Conference of the Nuclear Medicine Branch of the Chinese Medical Association was held in Xi 'an, Shaanxi Province from September 21 to 23, 2023. The opening ceremony was presided over by the standing member of the Nuclear Medicine Branch of the Chinese Medical Association, Professor LAN Xiaoli of the Nuclear Medicine Department of Wuhan Union Medical College Hospital
MOREOn October 5, 2023, the 15th Congress of the Asian-Oceanian Union for Nuclear Medicine and Biology (AOCNMB 2023), co-sponsored by the Asian-Oceanian Union for Nuclear Medicine (AOFNMB), the Arab Society for Nuclear Medicine, the Jordanian Society for Nuclear Medicine and the Asian-Oceanian Academy of Nuclear Medicine, opened in Amman, Jordan.
MORECopyright@2023 Zhejiang Repair Medical Technology Co., LTD All rights reserved ICP:18046259-1